论文信息 - A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma - 字舞流文

A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma

D. Schadendorf | A. Pavlick | K. Lewis | R. Carvajal | O. Hamid | F. Collichio | B. Chmielowski | D. O'Shannessy | C. Schweizer | A. Tarhini | S. Weil | J. Heyburn | S. D’Angelo